Oramed Pharmaceuticals
ORMP
#8949
Rank
NZ$0.32 B
Marketcap
NZ$8.06
Share price
-0.22%
Change (1 day)
126.83%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): NZ$1.44

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$1.42. In 2024 the company made an earnings per share (EPS) of NZ-$0.84 a decrease over its 2023 EPS that were of NZ$0.25.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.44-270.67%
2024NZ-$0.84-442.86%
2023NZ$0.25-114.89%
2022NZ-$1.6520.51%
2021NZ-$1.3739.29%
2020NZ-$0.98-31.71%
2019NZ-$1.44-4.65%
2018NZ-$1.518.86%
2017NZ-$1.38-9.2%
2016NZ-$1.5229.85%
2015NZ-$1.178.06%
2014NZ-$1.095.08%
2013NZ-$1.033.51%
2012NZ-$1.00137.5%
2011NZ-$0.42-60%
2010NZ-$1.05-0%
2009NZ-$1.05-16.67%
2008NZ-$1.26-25%
2007NZ-$1.68700%
2006NZ-$0.21303.56%
2005NZ-$0.05209

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
NZ$7.52 430.30%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$4.48 216.01%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
NZ-$10.70-854.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ-$0.33-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ-$0.53-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel